Abpro Holdings, Inc (ABP)
Abpro Holdings, Inc. develops novel antibody constructs for immuno-oncology and ophthalmology using its DiversImmune discovery platform and MultiMab engineering platform to create multi-specific antibodies. Its lead candidates include TetraBi antibodies targeting various cancer and vascular eye disease markers, designed to treat HER2+ solid tumors, vascular eye diseases, hepatocellular carcinoma, and gastric cancers.
Company Info
Highlights
$12.56M
-$0.43
$183.00K
$183.00K
-$8.49M
$0.16 - $13.00
$2.00
3.73%
0.04
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Abpro Holdings, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading data...
Returns By Period
Abpro Holdings, Inc (ABP) has returned -87.92% so far this year and -98.31% over the past 12 months.
ABP
- YTD
- -87.92%
- 1M
- -2.74%
- 6M
- -84.91%
- 1Y
- -98.31%
- 3Y*
- -72.43%
- 5Y*
- N/A
- 10Y*
- N/A
^GSPC (Benchmark)
- YTD
- 6.43%
- 1M
- 4.73%
- 6M
- 7.43%
- 1Y
- 11.48%
- 3Y*
- 17.91%
- 5Y*
- 14.47%
- 10Y*
- 11.49%
Monthly Returns
The table below presents the monthly returns of ABP, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Based on daily data since Mar 2022, the average daily return (also called the expected return) is -0.23%, while the average monthly return is -6.56%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -40.95% | -40.78% | -29.43% | -44.11% | -9.63% | -1.39% | -4.61% | -88.28% | |||||
| 2024 | 2.27% | -1.20% | 0.37% | 0.37% | 2.51% | 3.80% | -3.75% | -0.40% | 1.95% | 1.34% | -74.46% | -40.27% | -83.63% |
| 2023 | 0.88% | 0.54% | 0.44% | -0.48% | 0.19% | 0.68% | 0.29% | 0.57% | 0.29% | 0.57% | -0.00% | -0.19% | 3.83% |
| 2022 | 0.21% | 0.29% | 0.30% | 0.00% | 0.10% | 0.10% | 0.20% | 0.51% | 0.38% | 0.79% | 2.93% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ABP is 6, meaning it’s performing worse than 94% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Abpro Holdings, Inc (ABP) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Abpro Holdings, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abpro Holdings, Inc was 98.62%, occurring on May 14, 2025. The portfolio has not yet recovered.
The current Abpro Holdings, Inc drawdown is 98.31%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.62% | Jul 16, 2024 | 209 | May 14, 2025 | — | — | — |
| -7.37% | Jan 16, 2024 | 2 | Jan 17, 2024 | 85 | May 17, 2024 | 87 |
| -5.17% | May 24, 2024 | 9 | Jun 6, 2024 | 11 | Jun 24, 2024 | 20 |
| -2.83% | Apr 19, 2023 | 11 | May 3, 2023 | 74 | Aug 18, 2023 | 85 |
| -2.17% | Apr 14, 2023 | 2 | Apr 17, 2023 | 1 | Apr 18, 2023 | 3 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Abpro Holdings, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Abpro Holdings, Inc, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -425.0%.
Valuation
The Valuation section provides an overview of how Abpro Holdings, Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABP relative to other companies in the Biotechnology industry. Currently, ABP has a P/S ratio of 68.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABP in comparison with other companies in the Biotechnology industry. Currently, ABP has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |